Last reviewed · How we verify
NCT04923204
Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression
trial testing Pharmacogenomic-testing with NEUROPHARMAGEN in Bipolar Disorder in 76 participants. Completed in 5 December 2019.
31 March 2016
Quick facts
| Lead sponsor | AB Biotics, SA |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 76 |
| Start date | 1 March 2016 |
| Primary completion | 31 March 2016 |
| Estimated completion | 5 December 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Pharmacogenomic-testing with NEUROPHARMAGEN
Conditions studied
- Bipolar Disorder — all drugs for Bipolar Disorder →
Sponsor
AB Biotics, SA — full company profile →
Who can join
18 and older, any sex, with Bipolar Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation of the impact of the genetic variation of individual genes on the therapeutic response and side effects profile in a cohort of well-characterized patients with bipolar depression, using NEUROPHARMAGEN.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression.
Anmella G, Vilches S, Espadaler-Mazo J, Murru A, et al · · 2021 · cited 3× · PMID 34440433 · DOI 10.3390/genes12081259
Verify or expand the search:
- PubMed search for NCT04923204
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bipolar Disorder
Currently open trials in the same condition.
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT06911931 — Visual Perception in Schizophrenia · NA · recruiting
- NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
- NCT07479758 — Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Out · recruiting
- NCT07140913 — A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur · Phase 3 · recruiting
Other AB Biotics, SA trials
Trials by the same sponsor.
- NCT07193927 — Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Diseas · Phase 2 · not yet recruiting
- NCT06604234 — Impact of a Probiotic Combination on Quality of Life and Symptoms in Peri- and Postmenopausal Women · NA · completed
- NCT06193096 — Impact of a Probiotic-based Formula on Digestive Symptoms and Mood in Ultra Marathon Runners · NA · completed
- NCT05688397 — Evaluation of the Vaginal Colonization of Two New Lactobacillus Strains After Oral Administration in Healthy Volunteers · NA · completed
- NCT05524649 — Effect of Probiotics on Infant's Fecal Microbiota Composition · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04923204 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AB Biotics, SA
- Last refreshed: 11 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04923204.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing